The FDA plans to ban oral phenylephrine in cold medications due to its ineffectiveness.

The FDA has proposed banning oral phenylephrine, a common ingredient in over-the-counter cold medications, due to evidence showing it is ineffective for relieving nasal congestion. This proposal follows extensive review and public comments, with a final decision pending. If enacted, manufacturers must reformulate or remove products containing oral phenylephrine, though nasal spray forms remain unaffected. The move is not based on safety concerns.

November 07, 2024
160 Articles

Further Reading